PMI on track to submit PMTA to market its new Iqos vapour device in the US

Philip Morris International (PMI) has announced that it is continuing preparations to submit a premarket tobacco product application (PMTA) to the US Food and Drug Administration (FDA) in the second half of next year for a new Iqos e-vapour device.

The manufacturer said during its third-quarter earnings presentation that the product was making “good progress” in the markets where it has been launched so far.


Restricted content. Do you want to read more?